Introduction of the dengue vaccine in Brazil: the importance of a strengthened Unified Health System in confronting arboviruses
Authors:
- Ethel Leonor Noia MacielEMEthel Leonor Noia Maciel
- Carlos Augusto Grabois GadelhaCGCarlos Augusto Grabois Gadelha
- Eder Gatti FernandesEFEder Gatti Fernandes
- Jadher PercioJPJadher Percio
- Ana Catarina de Melo AraújoAAAna Catarina de Melo Araújo
- Thayssa Neiva da Fonseca VicterTVThayssa Neiva da Fonseca Victer
- Rivaldo Venâncio da CunhaRCRivaldo Venâncio da Cunha
- Guilherme Loureiro WerneckGWGuilherme Loureiro Werneck
- Nísia Trindade LimaNLNísia Trindade Lima
Open Access
- 1 January 2026
- journal article
- Published by FapUNIFESP (SciELO) in Revista Latino-Americana de Enfermagem
- Vol. 34
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Efficacy and safety of Butantan-DV in participants aged 2–59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in BrazilThe Lancet Infectious Diseases, 2024
- Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trialThe Lancet Global Health, 2024
- Vaccine confidence and hesitancy in BrazilCadernos de Saude Publica, 2018